FK506 Binding Protein 6, 36kDa (FKBP6) (Middle Region) Peptid
Kurzübersicht für FK506 Binding Protein 6, 36kDa (FKBP6) (Middle Region) Peptid (ABIN8100744)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- FKBP6 Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-MTA2 antibody ( ARP43599_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- FKBP6 (FK506 Binding Protein 6, 36kDa (FKBP6))
-
Hintergrund
-
Background Information: FKBP6 is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. FKBP6 is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin.This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. This protein is involved in palate formation.
Alternative Symbols: FKBP36, MGC87179, PPIase
-
Molekulargewicht
- 36kDa
-
Gen-ID
- 8468
-
NCBI Accession
- NP_003593
-
UniProt
- O75344
Target
-
